HOME >> BIOLOGY >> NEWS
Obtaining valid consent for doing large genetic studies in developing countries

Genetic research has the potential to improve global health by discovering what makes people susceptible or resistant to certain diseases, and what causes the diseases themselves, thereby guiding prevention efforts. Genetic studies, for example, are providing clues for scientists working on vaccines against HIV, malaria, and TB. But it is crucial, say Dave Chokshi (Wellcome Trust Centre for Human Genetics, University of Oxford) and colleagues in a policy paper in PLoS Medicine, to ensure that those who choose to participate in such research have given their fully informed consent.

While there has been much discussion setting out ethical principles for conducting medical research in low-income countries, there has been little discussion of how to apply these principles to large-scale genomic studies. The authors lay out a new set of ethical principles for obtaining ethically valid consent for such studies conducted in the developing world.

Citation: Chokshi DA, Thera MA, Parker M, Diakite M, Makani J, et al. (2007) Valid consent for genomic epidemiology in developing countries. PLoS Med 4(4): e95.

PLEASE ADD THE LINK TO THE PUBLISHED ARTICLE IN ONLINE VERSIONS OF YOUR REPORT: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040095

PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-04-04-chokshi.pdf

CONTACT:

Dave Chokshi
University of Pennsylvania
School of Medicine
3434 Sansom St.
Philadelphia, PA PA 19104
United States of America
+1 225-354-6673
daveash@med.upenn.edu


ALSO FROM THE PLoS MEDICINE MAGAZINE SECTION:

A case of unstable blood pressure


'"/>

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
23-Apr-2007


Page: 1 2

Related biology news :

1. UF study first to quantify validity of DNA I.D. tool using marine snails
2. Studies validating performance of Pall prion reduction technology presented at AABB
3. Status and reproduction in humans: New evidence for the validity of evolutionary explanations
4. New results validating Pall prion reduction filter disclosed at ISBT Congress
5. Novel approach yields predictions validated by experiments
6. Encouraging results from validation study of trial of personalized treatment in breast cancer
7. Truly informed consent must include talking about future fertility, warn experts
8. How does the brain know what the right hand is doing?
9. To avoid doing more harm than good, land trusts must consider market forces when acquiring property
10. Ability to listen to 2 things at once is largely inherited, says twin study
11. Link between obesity and enlarged heart discovered by University of Arizona researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/19/2020)... ... March 17, 2020 , ... ... microbiome populations down to the strain level, recently unveiled a convenient new solution ... kit contains the same innovative amplification capabilities as the Shoreline Complete kit. It ...
(Date:3/11/2020)... ... 11, 2020 , ... USARAD Holdings Inc., the leading US ... healthcare VC firms introduces a first of its kind COVID-19 screening program. The ... caused over 4,000 fatalities to date. Over the years, USARAD through its SecondOpinions.com ...
(Date:3/5/2020)... ... March 05, 2020 , ... ... of its Scientific Advisory Board (SAB) comprised of the industry’s key opinion ... cell therapy centers, and private industry. Cytonus is a leading cell-based platform ...
Breaking Biology News(10 mins):
(Date:3/13/2020)... ... March 12, 2020 , ... Today, DuPont Nutrition ... Research Center (APC), a pioneer in the field of microbiome science, which focuses ... role in human health, based at University College Cork and Teagasc Moorepark. , ...
(Date:3/10/2020)... ... ... Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving ... of extended antigen in a gel testing format used for blood phenotyping for patients ... Max in the United States and Canada. The clearances allow testing for more than ...
(Date:3/10/2020)... WORTH, Texas (PRWEB) , ... March 10, 2020 , ... ... manufacturing facility on 13 acres in Cleburne, Texas to be used as a biopharmaceutical ... as its global headquarters and sales offices as well as its production and development ...
(Date:3/4/2020)... , ... March 04, 2020 , ... This month, Cognosante ... Orlando, FL. The company will showcase both expanded and emerging offerings that align with ... 2020 is designed to be comprehensive, timely, and engaging. From Interoperability ...
Breaking Biology Technology:
Cached News: